Science RecorderFDA approves Zontivity to decrease risk of heart attack, strokeScience RecorderThe FDA says that medical professionals should notify patients of the increased risk of bleeding and bruising when taking Zontivity. FDA approves Zontivity to decrease risk of heart attack, stroke. Science Recorder | Jonathan Marker | Friday, May 09, 2014.Merck’s New Blood Clot Inhibitor Gets a Go-Ahead by FDA!YottaFireFDA approves new anti-clotting drug for heart patientsHealth24.comFDA Approves Blood-Clot Medication Zonitivity for Heart, StrokeArgyll Free PressPharmaTimes -Daily Digest -MedPage Todayall 39 news articles …Read Full Story
FDA approves Zontivity to decrease risk of heart attack, stroke - Science Recorder
Real Estate of Cebu
